ArticleMethods in molecular biology (Clifton, N.J.)2027
A Practical Compass to Biological Digital Resources and Omics Integration in Ewing Sarcoma.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ewing sarcoma (EwS) is a paradigmatic fusion-driven cancer in which oncogenic FET::ETS transcription factor fusions orchestrate complex regulatory, epigenomic, transcriptional, and proteomic programs. Despite extensive molecular profiling, biological insight, and translational progress, EwS are strongly shaped by how data are generated, structured, and shared across heterogeneous initiatives. Fragmented cohorts, uneven molecular depth, and limited longitudinal sampling influence both integrative analyses and systems-level interpretation. This chapter is organized around this structural reality. It first maps the current EwS data landscape, including patient-derived and preclinical omics datasets, profiling initiatives, repositories, and annotation resources, highlighting how their design and governance define the biological questions that can be addressed. It then synthesizes key biological insights derived from genomic, transcriptomic, epigenomic, proteomic, and single-cell studies, with an emphasis on regulatory logic, transcriptional plasticity, and context-dependent vulnerabilities revealed through integrative analyses. Particular attention is given to the predominance of preclinical approaches in systems-level EwS biology, reflecting the experimental resolution required to interrogate regulatory mechanisms that remain largely inaccessible in most patient cohorts. Finally, the chapter examines how these observations motivate a shift from opportunistic data aggregation toward intentionally designed EwS-specific data ecosystems. It discusses the technical, ethical, and organizational requirements for longitudinal, multilayer profiling and federated data access, and argues that such infrastructures are necessary to support reproducible systems biology and therapeutic translation in EwS.
Indexed as
Identifiers
42879031What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.